JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2003) 178, 5-12       DOI: 10.1677/joe.0.1780005
© 2003 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (38)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, A.
Journal of Endocrinology, Vol 178, Issue 1, 5-12
Copyright © 2003 by Society for Endocrinology


Articles

MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids?

AR Clark


Synthetic glucocorticoids (GCs) potently inhibit the expression of pro-inflammatory genes and are widely used in the treatment of inflammatory diseases. However, some patients are resistant to the therapeutic effects of GCs, and many suffer deleterious side effects from these drugs. Furthermore, the precise mechanisms by which GCs inhibit pro-inflammatory gene expression remain unclear. A number of recent papers report that GCs induce the sustained expression of MAP kinase (MAPK) phosphatase 1 (MKP-1), a negative regulator of MAPK signal transduction pathways. The potential relevance of MKP-1 to some of the biological effects of GCs is discussed.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
I. J. Cho and S. G. Kim
A Novel Mitogen-Activated Protein Kinase Phosphatase-1 and Glucocorticoid Receptor (GR) Interacting Protein-1-Dependent Combinatorial Mechanism of Gene Transrepression by GR
Mol. Endocrinol., January 1, 2009; 23(1): 86 - 99.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. R. Sutherland, E. Goleva, M. Strand, D. A. Beuther, and D. Y. M. Leung
Body Mass and Glucocorticoid Response in Asthma
Am. J. Respir. Crit. Care Med., October 1, 2008; 178(7): 682 - 687.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
P Bhavsar, M Hew, N Khorasani, A Torrego, P J Barnes, I Adcock, and K F Chung
Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma
Thorax, September 1, 2008; 63(9): 784 - 790.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. Quante, Y. C. Ng, E. E. Ramsay, S. Henness, J. C. Allen, J. Parmentier, Q. Ge, and A. J. Ammit
Corticosteroids Reduce IL-6 in ASM Cells via Up-Regulation of MKP-1
Am. J. Respir. Cell Mol. Biol., August 1, 2008; 39(2): 208 - 217.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. Horsch, H. de Wet, M. M. Schuurmans, F. Allie-Reid, A. C. B. Cato, J. Cunningham, J. M. Burrin, F. S. Hough, and P. A. Hulley
Mitogen-Activated Protein Kinase Phosphatase 1/Dual Specificity Phosphatase 1 Mediates Glucocorticoid Inhibition of Osteoblast Proliferation
Mol. Endocrinol., December 1, 2007; 21(12): 2929 - 2940.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Newton and N. S. Holden
Separating Transrepression and Transactivation: A Distressing Divorce for the Glucocorticoid Receptor?
Mol. Pharmacol., October 1, 2007; 72(4): 799 - 809.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. J. Dickinson and S. M. Keyse
Diverse physiological functions for dual-specificity MAP kinase phosphatases
J. Cell Sci., November 15, 2006; 119(22): 4607 - 4615.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. M. Abraham, T. Lawrence, A. Kleiman, P. Warden, M. Medghalchi, J. Tuckermann, J. Saklatvala, and A. R. Clark
Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1
J. Exp. Med., August 7, 2006; 203(8): 1883 - 1889.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. A. Giembycz and R. Newton
Beyond the dogma: novel {beta}2-adrenoceptor signalling in the airways.
Eur. Respir. J., June 1, 2006; 27(6): 1286 - 1306.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Sanchez-Tillo, M. Comalada, C. Farrera, A. F. Valledor, J. Lloberas, and A. Celada
Macrophage-Colony-Stimulating Factor-Induced Proliferation and Lipopolysaccharide-Dependent Activation of Macrophages Requires Raf-1 Phosphorylation to Induce Mitogen Kinase Phosphatase-1 Expression.
J. Immunol., June 1, 2006; 176(11): 6594 - 6602.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
X. Li, M. G. Schwacha, I. H. Chaudry, and M. A. Choudhry
A role of PP1/PP2A in mesenteric lymph node T cell suppression in a two-hit rodent model of alcohol intoxication and injury
J. Leukoc. Biol., March 1, 2006; 79(3): 453 - 462.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. J. Barnes
Corticosteroid effects on cell signalling
Eur. Respir. J., February 1, 2006; 27(2): 413 - 426.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. C. DeRuisseau, R. A. Shanely, N. Akunuri, M. T. Hamilton, D. Van Gammeren, A. M. Zergeroglu, M. McKenzie, and S. K. Powers
Diaphragm Unloading via Controlled Mechanical Ventilation Alters the Gene Expression Profile
Am. J. Respir. Crit. Care Med., November 15, 2005; 172(10): 1267 - 1275.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Wu, T. Pew, M. Zou, D. Pang, and S. D. Conzen
Glucocorticoid Receptor-induced MAPK Phosphatase-1 (MPK-1) Expression Inhibits Paclitaxel-associated MAPK Activation and Contributes to Breast Cancer Cell Survival
J. Biol. Chem., February 11, 2005; 280(6): 4117 - 4124.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Kaur, X. Liu, O. Gjoerup, A. Zhang, X. Yuan, S. P. Balk, M. C. Schneider, and M. L. Lu
Activation of p21-activated Kinase 6 by MAP Kinase Kinase 6 and p38 MAP Kinase
J. Biol. Chem., February 4, 2005; 280(5): 3323 - 3330.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Furst, C. Brueckl, W. M. Kuebler, S. Zahler, F. Krotz, A. Gorlach, A. M. Vollmar, and A. K. Kiemer
Atrial Natriuretic Peptide Induces Mitogen-Activated Protein Kinase Phosphatase-1 in Human Endothelial Cells via Rac1 and NAD(P)H Oxidase/Nox2-Activation
Circ. Res., January 7, 2005; 96(1): 43 - 53.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Homme, C. P. Schmitt, O. Mehls, and F. Schaefer
Mechanisms of Mitogen-Activated Protein Kinase Inhibition by Parathyroid Hormone in Osteoblast-Like Cells
J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2844 - 2850.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Bazuine, F. Carlotti, R. S. J. Tafrechi, R. C. Hoeben, and J. A. Maassen
Mitogen-Activated Protein Kinase (MAPK) Phosphatase-1 and -4 Attenuate p38 MAPK during Dexamethasone-Induced Insulin Resistance in 3T3-L1 Adipocytes
Mol. Endocrinol., July 1, 2004; 18(7): 1697 - 1707.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Wu, S. Chaudhuri, D. R. Brickley, D. Pang, T. Karrison, and S. D. Conzen
Microarray Analysis Reveals Glucocorticoid-Regulated Survival Genes That Are Associated With Inhibition of Apoptosis in Breast Epithelial Cells
Cancer Res., March 1, 2004; 64(5): 1757 - 1764.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society for Endocrinology.